G-bucal-c
NDC 43913-402
Product Information
G-bucal-c is a OTC MONOGRAPH NOT FINAL-approved product labeled by Mclaren Medical Inc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 43913-402 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 43913-402?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (Active Moiety)
- ZINC CHLORIDE (UNII: 86Q357L16B)
- ZINC CATION (UNII: 13S1S8SF37) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZOCAINE (UNII: U3RSY48JW5)
- CETYLPYRIDINIUM CHLORIDE (UNII: D9OM4SK49P)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- GLYCERIN (UNII: PDC6A3C0OX)
- PEPPERMINT OIL (UNII: AV092KU4JH)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- WATER (UNII: 059QF0KO0R)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1291083 - benzocaine 2 % / cetylpyridinium Cl 0.1 % / menthol 0.15 % / zinc chloride 0.1 % Mucosal Spray
- RxCUI: 1291083 - benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 1.5 MG/ML / zinc chloride 1 MG/ML Mucosal Spray
- RxCUI: 1291083 - benzocaine 2 % / cetylpyridinium Cl 0.1 % / menthol 1.5 % / zinc chloride 0.1 % Mucosal Spray
* Please review the full disclaimer at the bottom of this page.